CategoryBiometric wearables
Overview
Nia Therapeutics (Nia TX) is a San Francisco-based brain-computer interface company developing an AI-guided brain implant for memory loss. Its Smart Neurostimulation System (SNS) uses closed-loop neurostimulation to improve memory in patients with traumatic brain injury and cognitive disorders. FDA Breakthrough Device Designation granted; first device to receive this designation for memory loss. 60-channel wireless AI-enabled platform validated in vivo.
Verified record
- Verified deployments
- 2 deployments on file
- Active incidents
- 1 incident on file
Data & sources
Press releases
2
2 sources backing this record.View all →
Models (1)
View all models →Nia Therapeutics on the deployment map
View the global map2 verified deployments across 2 regions, newest verified Jun 2024. Explore where Nia Therapeutics's robots are operating, by place and type.
Relationships
Current leadership (3)
- Dr. Michael Kahana Founder and CEOsecondary-verified
- Dr. Daniel Rizzuto Founder, President and CTOsecondary-verified
- Daniel Utin Chief Software Architectsecondary-verified
Founders (2)
- Dr. Michael Kahanacofounderno longer at company
- Dr. Daniel Rizzutocofounderno longer at company
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Nia Therapeutics (1)
- FDA grants Breakthrough Device Designation for NIA Therapeutics memory restoration implant2026-03-01 · Regulatory action
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Operator customers (1)
- Nia Therapeutics2 deployments
Recent coverage
Nia Therapeutics in third-party press
Peer companies
- Google12 models
- Samsung Electronics6 models
- Abbott2 models
- Butterfly Network2 models
- Apple1 model
- Blackrock Neurotech1 model
Mentioned on (5)
Registry pages whose text names Nia Therapeutics.
Robots and products (1)
People (3)
Funding rounds (1)
- Equity Financing2024-05-03
$9M(reported)
Timeline
Every recorded move in Nia Therapeutics’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
Funding roundEquity Financing funding round
2024-03-03Equity Financing
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdAug 8, 2026
Added to the verified registry
- Incident recordedMar 1, 2026
FDA grants Breakthrough Device Designation for NIA Therapeutics memory restoration implant
- Deployment recordedJun 1, 2024
Nia Smart Neurostimulation System at United States
- Deployment recordedJun 1, 2024
Nia Smart Neurostimulation System at Germany, Europe
Sources (2)
Common questions
What is Nia Therapeutics?
What does Nia Therapeutics make?
Is Nia Therapeutics publicly traded?
Who competes with Nia Therapeutics?
Who is the CEO of Nia Therapeutics?
How can I invest in Nia Therapeutics?
Where is Nia Therapeutics headquartered?
Who owns Nia Therapeutics?
Where does Nia Therapeutics operate robots?
How many robots has Nia Therapeutics deployed?
Is Nia Therapeutics a top robotics company?
Are there any incidents involving Nia Therapeutics?
Is Nia Therapeutics safe?
Methodology: Verified · 2 sources (2 primary) · last reviewed 2026-10-13
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-10-13
Sources by quality tier
- 2
- primary-company-ir
- Company IR disclosure
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Nia Therapeutics.Peer companies
- Google12 models
- Samsung Electronics6 models
- Abbott2 models
- Butterfly Network2 models
- Apple1 model
- Blackrock Neurotech1 model
In the press
Recent coverage mentioning Nia Therapeutics from third-party publications. Automatically surfaced; not part of the verified registry record.
Nia Therapeutics wins FDA breakthrough nod for neuromod that treats memory loss
MassDevice coverage of Nia Therapeutics receiving FDA Breakthrough Device Designation for its Smart Neurostimulation System (SNS). The device records neural activity from 60…
Nia Therapeutics Receives FDA Breakthrough Device Designation for AI-Guided Brain Implant to Treat Memory Loss
Nia Therapeutics announced FDA Breakthrough Device Designation for its Smart Neurostimulation System (SNS) for treating episodic memory loss in adults with prior…
Nia Therapeutics plans FIH memory loss implant trial after FDA green light
Medical Device Network reports Nia Therapeutics plans to file an IDE application for a first-in-human (FIH) study of its Smart Neurostimulation System after receiving FDA…
About Us | Nia TX – Innovating Memory Therapeutics
Nia Therapeutics (Nia TX) company page. Founded 2018, spun out of University of Pennsylvania. Timeline: DARPA Restoring Active Memory project began 2014 at UPenn; 2018 first…
Nia Therapeutics Raises .5 Million
Penn Center for Innovation reports that Penn spinout Nia Therapeutics raised .5 million in an equity financing round. Company co-founded by Michael Kahana, PhD, Kahn Term…
Machine-readable surfaces
- Markdown mirror: /companies/nia-therapeutics.md
- RSS feed: /companies/nia-therapeutics/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/2dd92afc-8a32-4c63-b5ad-b45fd0afeb88
- Revision history: /companies/nia-therapeutics/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Google12 models
- Samsung Electronics6 models
- Abbott2 models
- Butterfly Network2 models
- Apple1 model
- Blackrock Neurotech1 model
Video
NIA Creative developed a 3D Mechanism of Action Animation (MOA) showcasing their transcutaneous delivery of large macromolecules. This animation is silent, util
Heat Index
Serious50/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Nia Therapeutics draws attention at the 20th percentile but verifies reality at the 48th percentile among biometric robots. Hype Gap -28.1, 24th widest among biometric robots.
6-month trend
Analysis
Safety profile within acceptable range for category. Deployment footprint remains limited relative to category peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Nov 7, 2026